mGluR5 PET显像可定位内侧颞叶癫痫致痫区
术后无发作患者同侧内嗅皮质结合电位更低,提示mGluR5可能成为治疗靶点。
要点
- MTLE患者致痫区海马头和杏仁核[11C]ABP688 BPND局灶性降低。
- [11C]ABP688 PET定位致痫区较[18F]FDG PET空间准确性更高。
- 术后Engel Ia患者同侧内嗅皮质[11C]ABP688 BPND显著更低。
核心结论
- [11C]ABP688 PET可为MTLE致痫区提供局灶性生物标志物,空间准确性高于[18F]FDG PET。
主要发现
- 致痫区海马头和杏仁核[11C]ABP688 BPND局灶性降低(p < 0.001)。
- 伴海马萎缩患者异常更广泛,累及同侧颞叶新皮质(p = 0.006)。
- [11C]ABP688 BPND半球间差异幅度更大,区分致痫结构较[18F]FDG摄取更准确。
- 25例手术患者中23例随访>1年,13例无发作(Engel Ia),其同侧内嗅皮质[11C]ABP688 BPND显著更低。
临床怎么用
- 对MTLE术前评估,[11C]ABP688 PET可能辅助致痫区定位,尤其当[18F]FDG PET显示广泛代谢减低时。
- mGluR5异常可能反映谷氨酸过多导致的受体内化或构象改变,支持其作为治疗靶点。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Surgical specimens from patients with mesial temporal lobe epilepsy (MTLE) show abnormalities in tissue concentrations of metabotropic glutamate receptor type 5 (mGluR5). To clarify whether these abnormalities are specific to the epileptogenic zone (EZ), we characterized in vivo whole-brain mGluR5 availability in MTLE patients using positron emission tomography (PET) and [11 C]ABP688, a radioligand that binds specifically to the mGluR5 allosteric site. METHODS: Thirty-one unilateral MTLE patients and 30 healthy controls underwent [11 C]ABP688 PET. We compared partial volume corrected [11 C]ABP688 nondisplaceable binding potentials (BPND ) between groups using region-of-interest and whole-brain voxelwise analyses. [18 F]Fluorodeoxyglucose (FDG) PET was acquired in 15 patients, for whom we calculated asymmetry indices of [11 C]ABP688 BPND and [18 F]FDG uptake to compare lateralization and localization differences. RESULTS: [11 C]ABP688 BPND was focally reduced in the epileptogenic hippocampal head and amygdala (p < 0.001). Patients with hippocampal atrophy showed more extensive abnormalities, including the ipsilateral temporal neocortex (p = 0.006). [11 C]ABP688 BPND showed interhemispheric differences of higher magnitude and discriminated the epileptogenic structures more accurately when compared to [18 F]FDG uptake, which showed more widespread hypometabolism. Among 23 of 25 operated patients with >1 year of follow-up, 13 were seizure-free (Engel Ia) and showed significantly lower [11 C]ABP688 BPND in the ipsilateral entorhinal cortex. INTERPRETATION: [11 C]ABP688 PET provides a focal biomarker for the EZ in MTLE with higher spatial accuracy compared to [18 F]FDG PET. Focally reduced mGluR5 availability in the EZ might reflect receptor internalization or conformational changes in response to excessive extracellular glutamate, supporting a potential role for mGluR5 as therapeutic target in human MTLE. Ann Neurol 2019; 1-11 ANN NEUROL 2019;85:218-228.
引用
- Lam J, DuBois JM, Rowley J, et al. In vivo metabotropic glutamate receptor type 5 abnormalities localize the epileptogenic zone in mesial temporal lobe epilepsy. Ann Neurol. 2019. PMID: 30597619. doi:10.1002/ana.25404
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。